Treatment with bortezomib in dense deposit disease associated with monoclonal gammopathy of undetermined significance
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Haematology"
DOI: 10.1111/bjh.15081
Abstract: Ibrutinib treatment for 72 hours at 5 doses in MCL lines, IR, ibrutinib resistance. IC50s were calculated using GraphPad Prism software. (B) CCK8 assay showing the effects of ABT199, AZD8055 and the combination of ABT-199… read more here.
Keywords: abt 199; ibrutinib; treatment; combination abt ... See more keywords